Selection of the solvent system for the preparation of poly(D,L-lactic-co-glycolic acid) microspheres containing tumor necrosis factor-alpha (TNF-α)

被引:19
作者
Iwata, M
Tanaka, T
Nakamura, Y
McGinity, JW
机构
[1] Dainippon Pharmaceut Co Ltd, Pharmaceut Res Labs, Fukushima Ku, Osaka 553, Japan
[2] Dainippon Pharmaceut Co Ltd, Dept Pharmaceut Technol, Fukushima Ku, Osaka 553, Japan
[3] Univ Texas, Coll Pharm, Austin, TX 78712 USA
关键词
acetonitrile; anhydrous solvent evaporation system; dichloromethane; matrix-type microspheres; multiphase microspheres; poly(D; L-lactic-co-glycolic acid); stability of TNF-alpha;
D O I
10.1016/S0378-5173(97)00306-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dichloromethane (DCM) and acetonitrile (ACN) are the most commonly used solvents for polylactic acid (PLA) or poly(lactic-co-glycolic acid) (PLGA). In order to select a suitable solvent system for the preparation of PLGA microspheres containing tumor necrosis factor-alpha (TNF-alpha), the stability of TNF-alpha when mixed with DCM and ACN under various phase conditions was investigated. When the TNF-alpha solution was emulsified into DCM to form a W/O emulsion prior to solvent evaporation using the W/O/W technique, a significant loss in activity of TNF-alpha was found. When the TNF-alpha was dispersed as a dry powder in the DCM phase, the protein was inactivated due to immediate hydration under the conditions of the solid/O/W system. Since TNF-alpha also was inactivated in a buffered saline containing ACN, the stability of the protein in microspheres prepared from an anhydrous solvent system was studied using ACN as the polymer solvent. Multiphase microspheres prepared by an anhydrous multiple emulsion process had a significantly higher loading efficiency of intact TNF-alpha than conventional matrix-type microspheres prepared by an anhydrous method using TNF-alpha powder and ACN. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:145 / 156
页数:12
相关论文
共 23 条
[1]  
BECK L R, 1985, Advances in Contraception, V1, P119, DOI 10.1007/BF01849793
[2]   POLYLACTIC ACID MICROSPHERES CONTAINING QUINIDINE BASE AND QUINIDINE SULFATE PREPARED BY THE SOLVENT EVAPORATION TECHNIQUE .1. METHODS AND MORPHOLOGY [J].
BODMEIER, R ;
MCGINITY, JW .
JOURNAL OF MICROENCAPSULATION, 1987, 4 (04) :279-288
[3]   THE PREPARATION AND EVALUATION OF DRUG-CONTAINING POLY(DL-LACTIDE) MICROSPHERES FORMED BY THE SOLVENT EVAPORATION METHOD [J].
BODMEIER, R ;
MCGINITY, JW .
PHARMACEUTICAL RESEARCH, 1987, 4 (06) :465-471
[4]  
CHIEN YW, 1983, CONTROLLED DRUG DELI, P481
[5]  
CSERNUS VJ, 1990, INT J PEPT PROT RES, V35, P557
[6]   BIODEGRADABLE NANOPARTICLES FOR SUBCUTANEOUS ADMINISTRATION OF GROWTH-HORMONE RELEASING-FACTOR (HGRF) [J].
GAUTIER, JC ;
GRANGIER, JL ;
BARBIER, A ;
DUPONT, P ;
DUSSOSSOY, D ;
PASTOR, G ;
COUVREUR, P .
JOURNAL OF CONTROLLED RELEASE, 1992, 20 (01) :67-77
[7]  
HEYA T, 1991, INT J PHARMACEUT, V69, P69
[8]   DISSOLUTION, STABILITY, AND MORPHOLOGICAL PROPERTIES OF CONVENTIONAL AND MULTIPHASE POLY(DL-LACTIC-CO-GLYCOLIC ACID) MICROSPHERES CONTAINING WATER-SOLUBLE COMPOUNDS [J].
IWATA, M ;
MCGINITY, JW .
PHARMACEUTICAL RESEARCH, 1993, 10 (08) :1219-1227
[9]  
IWATA M, 1992, J MICROENCAPSUL, V9, P201
[10]   MICROENCAPSULATION USING POLY (L-LACTIC ACID) .2. PREPARATIVE VARIABLES AFFECTING MICROCAPSULE PROPERTIES [J].
JALIL, R ;
NIXON, JR .
JOURNAL OF MICROENCAPSULATION, 1990, 7 (01) :25-39